SIREN : 500392410
BIOLAP is a French company founded 18 years ago, specialized in the sector Fonds de placement et entités financières similaires. Based in VALREAS (84600), this company of category PME shows in 2024 a net income positive of 229 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C |
| Net income | 228 762 € | 305 960 € | -375 873 € | 6 567 501 € | 688 220 € | 407 667 € | 440 417 € | 391 896 € | 263 901 € |
| EBITDA | -50 986 € | -63 170 € | -72 085 € | -54 550 € | -42 923 € | -33 848 € | -30 299 € | -32 994 € | -32 328 € |
| Net margin | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C |
In 2024, BIOLAP generates positive net income of 229 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 264 k€ -> 229 k€.
-50 986 €
-53 248 €
228 762 €
The debt ratio (= Financial debt / Equity x 100) stands at 6%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 6%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 2.8 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability.
6.353%
5.801%
2.78
92.2%
In 2024, the debt ratio of BIOLAP (6.35) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2024, the financial autonomy of BIOLAP (5.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of BIOLAP (2.78) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 580.17. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
580.167
-109.175
In 2024, the liquidity ratio of BIOLAP (580.17) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of BIOLAP (-109.2x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 25 days. Favorable situation: supplier credit is longer than customer credit by 25 days.
0 €
0 j
25 j
0 j
Indicative estimate only : the number of comparable transactions in this sector is limited (26 transactions). This range of 642 517€ to 4 433 085€ is provided for information purposes only and requires in-depth analysis to be confirmed.
This estimate is based on the analysis of 26 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare BIOLAP with other companies in the same sector:
Voir toutes les statistiques du secteur Fonds de placement et entités financières similaires
The revenue of BIOLAP is not publicly disclosed (confidential accounts filed with INPI).
Yes, BIOLAP generated a net profit of 229 k€ in 2024.
The headquarters of BIOLAP is located in VALREAS (84600), in the department Vaucluse.
The tax return of BIOLAP is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
BIOLAP operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.